MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Prodromal Clinical Markers of Parkinson disease in patients with Gaucher disease and their parents

WZ. Hu, Q. Yang, Y. Huang (Guangzhou, China)

Meeting: 2025 International Congress

Keywords: Non-motor Scales, Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms (non-Cognitive/ non-Psychiatric)

Objective: To determine the presence of prodromal markers of Parkinson’s disease (PD) in Gaucher disease (GD) patients and their parents.

Background: GBA gene mutation is the main genetic risk factor for PD. GD, an autosomal recessive lysosomal storage disorder caused by GBA gene mutations, implies that both parents of the GD contracted individuals carry GBA mutations. Consequently, patients of GD and their parents may face a higher risk of developing PD compared to the general population. Investigating prodromal symptoms of PD in populations with GBA mutations is of significant value, as it will enhance our understanding of GBA as an independent risk factor for PD. Few studies have investigated the prodromal symptoms of PD in people with GD and their parents.

Method: GD patients and parents were recruited from a China-based non-profit Gaucher Care Group, with confirmed GD diagnoses (clinical manifestations + GBA activity). From Nov/2022 to Apr/2023, demographic data and PD prodromal markers (according MDS prodromal criteria, including olfactory dysfunction, constipation, daytime somnolence, hypotension, erectile/urinary dysfunction, depression, RBD) were assessed via online interviews using Non-Motor Symptoms Scale/RBD Single Question Screen.

Results: A total of 51 subjects (average age 27.84±14.50 years) from China were included in this study, including 27 GD patients (17 males, 10 females, average age 20.67±14.36 years) and 24 GD patients’ parents (13 males, 11 females, average age 35.92±9.76 years). Of these 51 individuals, mutations were commonly seen in the encoding glycol_hydro 30 domain, followed by 30C domain and then the signal peptide domain. The most common GBA mutation site is c.1448T to C or A. Constipation (11, 21.6%), RBD (10, 19.6%), urinary dysfunction (8, 15.7%), depression (5, 9.8%), symptomatic hypotension (5, 9.8%), daytime somnolence (3, 5.9%), erectile dysfunction (2, 3.9%), and hyposmia (1, 2.0%) were observed in GD patients and their parents.

Conclusion: The c.1448T mutation is prevalent in Chinese GD patients and their parents. GD patients and their parents exhibit a higher prevalence of prodromal symptoms of PD.

To cite this abstract in AMA style:

WZ. Hu, Q. Yang, Y. Huang. Prodromal Clinical Markers of Parkinson disease in patients with Gaucher disease and their parents [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/prodromal-clinical-markers-of-parkinson-disease-in-patients-with-gaucher-disease-and-their-parents/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/prodromal-clinical-markers-of-parkinson-disease-in-patients-with-gaucher-disease-and-their-parents/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley